Nov 13, 2024 / 05:30AM GMT
Operator
Good morning. Ladies and gentlemen, welcome to the Natco Pharma Q2 FY25 earnings conference call hosted by Batlivala & Karani Securities India Private Limited.
(Operator Instructions)
I now hand the conference over to Mr. Hrishikesh Patole from Batlivala & Karani Securities India Private Limited. Thank you and over to you, sir.
Hrishikesh Patole - Batlivala & Karani Securities India Private Limited - Investor Relations
Oh, hello, good morning everyone.
On behalf of B&K Securities, I welcome you all to the Q2 FY25 earnings conference call of Natco Pharma.
Hope everyone is in good health and doing well.
On behalf of Natco today, we have with us Mr. Rajeev Nannapaneni, Director and CEO, Mr. Rajesh Chebiyam, Executive Vice President, Crop Health Sciences. I now hand over the call to Rajesh for the management's opening remarks post which will open the session for Q&A. Over to you sir.
Rajesh Chebiyam - Natco Pharma Ltd - Executive Vice President, Crop Health Sciences<
Q2 2025 Natco Pharma Ltd Earnings Call Transcript
Nov 13, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers